Rafarma Pharmaceuticals had a revenue of 108.00K in the quarter ending Jun 30, 2024, with -50.91%. This bring the company's revenue in the last twelve months to 6.01M, Increased -64.18%. In the fiscal year ending Dec 31, 2023, Rafarma Pharmaceuticals had annual revenue of 10.13M with -84.24% growth.